FMO2

flavin containing dimethylaniline monoxygenase 2, the group of Flavin containing monooxygenases

Basic information

Region (hg38): 1:171185249-171212686

Links

ENSG00000094963NCBI:2327OMIM:603955HGNC:3770Uniprot:Q99518AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FMO2 gene.

  • not_specified (58 variants)
  • not_provided (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FMO2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001460.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
2
missense
58
clinvar
3
clinvar
61
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 58 5 0
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FMO2protein_codingprotein_codingENST00000441535 827476
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.14e-70.783111898842130071257470.0567
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.09932562610.9830.00001363111
Missense in Polyphen8698.6580.87171233
Synonymous0.5678591.90.9250.00000486876
Loss of Function1.361319.50.6679.05e-7260

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.3230.324
Ashkenazi Jewish0.08960.0901
East Asian0.0008720.000870
Finnish0.02400.0237
European (Non-Finnish)0.04810.0478
Middle Eastern0.0008720.000870
South Asian0.05330.0528
Other0.05300.0525

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the N-oxidation of certain primary alkylamines to their oximes via an N-hydroxylamine intermediate. Inactive toward certain tertiary amines, such as imipramine or chloropromazine. Can catalyze the S-oxidation of methimazole. The truncated form is catalytically inactive. {ECO:0000269|PubMed:9804831}.;
Pathway
Drug metabolism - cytochrome P450 - Homo sapiens (human);Busulfan Pathway, Pharmacodynamics;Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs);Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;FMO oxidises nucleophiles;Biological oxidations;Metabolism;Selenoamino acid metabolism;nicotine degradation IV (Consensus)

Intolerance Scores

loftool
0.941
rvis_EVS
2.47
rvis_percentile_EVS
98.61

Haploinsufficiency Scores

pHI
0.116
hipred
N
hipred_score
0.285
ghis
0.404

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.229

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Fmo2
Phenotype

Gene ontology

Biological process
organic acid metabolic process;NADP metabolic process;xenobiotic metabolic process;toxin metabolic process;drug metabolic process;NADPH oxidation;oxygen metabolic process
Cellular component
endoplasmic reticulum membrane;membrane;organelle membrane
Molecular function
monooxygenase activity;N,N-dimethylaniline monooxygenase activity;flavin adenine dinucleotide binding;NADP binding